CARLSMED, INC.

Public Equity (NASDAQ)Medical TechnologyAISpine Surgery

📍 Carlsbad, CA, USA

StreetZero Signal 54

Be the first to signal interest

About CARLSMED, INC.

Carlsmed, Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The company is headquartered in Carlsbad, California, and focuses on personalized spine surgery solutions. Carlsmed completed its IPO on July 23, 2025, with shares trading on the Nasdaq Global Select Market under the ticker CARL.

LATEST FUNDINGRule 144

$58K

Announced 2026-10-14

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for CARLSMED, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQCarlsbad, CA, USA

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Carlsmed completed a $100.5 million IPO on July 23, 2025, listing on Nasdaq under ticker CARL.
The company specializes in AI-enabled personalized spine surgery solutions.
IPO was advised by Morrison Foerster with lead underwriters BofA Securities, Goldman Sachs, and Piper Sandler.
Carlsmed is based in Carlsbad, California, and has appointed key executives including a Chief Product and AI Officer.

Ask StreetZero about CARLSMED, INC.

Put our AI to work on this deal.

What is CARLSMED, INC.'s value proposition?Who are CARLSMED, INC.'s competitors?Why does this raise matter?Summarize CARLSMED, INC. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Palo Alto Networks Inc

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.